Pacific Biosciences of California (PACB) Misses Q4 EPS by 2c

February 5, 2013 4:09 PM EST Send to a Friend
Get Alerts PACB Hot Sheet
Trade PACB Now!
Join SI Premium – FREE
Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q4 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $4.38 million.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment